0,980  0,000  Adenosine deaminase inhibitor
0,935  0,002  Cytostatic
0,902  0,001  Antineoplastic antimetabolite
0,899  0,002  DNA synthesis inhibitor
0,883  0,000  NADH dehydrogenase inhibitor
0,877  0,000  Adenosine kinase inhibitor
0,861  0,001  RNA-directed DNA polymerase inhibitor
0,851  0,001  Adenosine A1 receptor antagonist
0,832  0,001  Antiviral (Poxvirus)
0,790  0,002  DNA methylase inhibitor
0,785  0,000  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,787  0,004  Vasodilator, peripheral
0,777  0,001  Argininosuccinate synthase inhibitor
0,764  0,005  Antineoplastic (solid tumors)
0,737  0,003  Antiviral (Herpes)
0,734  0,001  Adenylate cyclase inhibitor
0,730  0,002  Glutamate dehydrogenase inhibitor
0,732  0,005  Proliferative diseases treatment
0,725  0,001  Phosphofructokinase-1 inhibitor
0,728  0,005  Immunomodulator
0,728  0,004  Vasodilator, coronary
0,717  0,001  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,714  0,001  Thymidine kinase inhibitor
0,715  0,002  DNA methyltransferase I inhibitor
0,714  0,004  Antineoplastic (non-Hodgkin's lymphoma)
0,693  0,001  Carbamoyl phosphate synthetase inhibitor
0,693  0,002  Adenosine A2a receptor antagonist
0,676  0,002  Adenosine A2 receptor antagonist
0,687  0,017  Teratogen
0,671  0,006  Antineoplastic (myeloid leukemia)
0,668  0,004  Cyclic AMP phosphodiesterase inhibitor
0,659  0,001  Fumarate hydratase inhibitor
0,656  0,002  Adenosine A3 receptor antagonist
0,641  0,007  Cardioprotectant
0,637  0,009  Cytotoxic
0,645  0,019  Embryotoxic
0,627  0,005  Antineoplastic (osteosarcoma)
0,624  0,005  Antineoplastic (lymphoma)
0,618  0,004  Antiviral (Hepatitis)
0,632  0,020  Antileukemic
0,599  0,001  UDP-glucose 4-epimerase inhibitor
0,600  0,017  Immunostimulant
0,582  0,002  Antimetabolite
0,550  0,001  Adenylate kinase inhibitor
0,550  0,002  DNA repair enzyme inhibitor
0,551  0,004  Antiviral (Hepatitis B)
0,547  0,002  Adenosine A1 receptor agonist
0,547  0,003  DNA polymerase I inhibitor
0,547  0,005  Cytidine deaminase inhibitor
0,540  0,007  Antineoplastic (lymphocytic leukemia)
0,561  0,032  TNF expression inhibitor
0,529  0,005  Radiosensitizer
0,518  0,001  Phosphoglycerate kinase inhibitor
0,517  0,007  Antiviral (HIV)
0,506  0,001  Biliverdin reductase inhibitor
0,513  0,013  DNA damaging
0,500  0,004  Antiviral (Hepatitis C)
0,483  0,016  Antiprotozoal (Trypanosoma)
0,474  0,023  Mutagenic
0,451  0,005  Aldehyde dehydrogenase inhibitor
0,440  0,001  Antiviral (Herpesvirus 3, Human)
0,472  0,041  Immunosuppressant
0,434  0,003  Ornithine carbamoyltransferase inhibitor
0,439  0,016  Antineoplastic enhancer
0,417  0,001  Purinergic P2X1 antagonist
0,401  0,002  Purinergic P2Y antagonist
0,397  0,004  Aminoacyl-tRNA synthetase inhibitor
0,405  0,015  Septic shock treatment
0,441  0,060  Antibacterial
0,411  0,033  Chemoprotective
0,418  0,046  Cholesterol antagonist
0,375  0,004  Antiviral (Influenza B)
0,370  0,005  Hexokinase inhibitor
0,363  0,001  Nucleoside transporters inhibitor
0,383  0,021  Interleukin agonist
0,362  0,009  Antidiabetic (type 1)
0,378  0,027  Vasodilator
0,375  0,025  Antineoplastic (endocrine cancer)
0,360  0,011  Peptidyltransferase inhibitor
0,354  0,010  Alkylator
0,361  0,022  Antineoplastic (bladder cancer)
0,339  0,001  Acyl-CoA dehydrogenase inhibitor
0,336  0,003  Heat shock protein 70 antagonist
0,361  0,030  Antineoplastic (small cell lung cancer)
0,329  0,001  Thymidine phosphorylase inhibitor
0,372  0,048  Antimycobacterial
0,332  0,011  Interleukin 6 antagonist
0,320  0,002  S-adenosyl-L-homocysteine hydrolase inhibitor
0,344  0,026  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,320  0,004  Ribonucleotide reductase inhibitor
0,350  0,043  Sensitization
0,310  0,002  Equilibrative nucleoside transport protein inhibitor
0,311  0,005  Antiviral (West Nile virus)
0,342  0,036  Antineoplastic (liver cancer)
0,313  0,015  Diabetic nephropathy treatment
0,300  0,003  Antiviral (Dengue virus)
0,307  0,010  Sulfotransferase substrate
0,300  0,006  Antiviral (CMV)
0,346  0,053  Antineoplastic (brain cancer)
0,341  0,054  Radioprotector
0,304  0,017  Antineoplastic (gastric cancer)
0,287  0,001  Adenosine A2 receptor agonist
0,282  0,004  Antiprotozoal (Toxoplasma)
0,299  0,022  Antineoplastic (carcinoma)
0,353  0,076  Transcription factor NF kappa B inhibitor
0,321  0,046  Cardiodepressant
0,277  0,005  Antiviral (Ebola)
0,322  0,052  Antineoplastic (cervical cancer)
0,287  0,019  Protein kinase stimulant
0,292  0,029  Ca2+/calmodulin-dependent kinase IV inhibitor
0,330  0,072  ICAM1 expression inhibitor
0,284  0,027  Protein kinase C nu inhibitor
0,263  0,009  Antiprotozoal (Trichomonas)
0,255  0,002  Adenosine A2b receptor agonist
0,325  0,074  Antithrombotic
0,294  0,045  Antineoplastic (sarcoma)
0,282  0,035  Antiviral (Influenza)
0,251  0,004  Neutropenia treatment
0,263  0,019  Acute respiratory distress syndrome (ARDS) treatment
0,371  0,128  Apoptosis agonist
0,264  0,022  Phospholipase C inhibitor
0,242  0,002  Adenosine A3 receptor agonist
0,243  0,004  Adenylate cyclase stimulant
0,242  0,005  Ribonucleoside-diphosphate reductase inhibitor
0,242  0,007  Xanthine oxidase substrate
0,233  0,010  DNA directed RNA polymerase inhibitor
0,328  0,105  CYP2C19 inhibitor
0,220  0,002  S-adenosyl-L-methionine decarboxylase inhibitor
0,279  0,075  Antituberculosic
0,209  0,006  Antiviral (Papilloma)
0,197  0,001  Adenosine A2a receptor agonist
0,274  0,079  Antineoplastic (pancreatic cancer)
0,274  0,081  Hypoxia-inducible factor 1 alpha inhibitor
0,300  0,107  Ulceration
0,194  0,002  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,192  0,000  Purinergic P2Y1 agonist
0,271  0,084  Antineoplastic (multiple myeloma)
0,266  0,079  UGT2B4 substrate
0,253  0,069  Angiogenesis stimulant
0,276  0,092  Interleukin 2 agonist
0,237  0,054  Antialcoholic
0,236  0,058  Carcinogenic
0,191  0,014  Protein kinase C mu inhibitor
0,192  0,019  MAP3K9 inhibitor
0,199  0,027  Glutathione S-transferase substrate
0,183  0,012  Actinic keratosis treatment
0,271  0,101  AR expression inhibitor
0,194  0,025  CF transmembrane conductance regulator agonist
0,174  0,007  Purinergic P2X2 antagonist
0,168  0,002  AICAR transformylase inhibitor
0,173  0,008  Histamine N-methyltransferase inhibitor
0,198  0,035  MAP kinase kinase 5 inhibitor
0,202  0,040  NOS3 expression enhancer
0,160  0,005  Adenosine A2b receptor antagonist
0,197  0,043  Antineoplastic (squamous cell carcinoma)
0,178  0,026  Expectorant
0,213  0,063  UDP-glucuronosyltransferase substrate
0,192  0,043  UGT2B10 substrate
0,165  0,017  Alcohol dehydrogenase inhibitor
0,220  0,075  EphB2 antagonist
0,182  0,040  Alpha-N-acetylglucosaminidase inhibitor
0,163  0,023  Aldehyde dehydrogenase substrate
0,229  0,091  Antineoplastic (renal cancer)
0,181  0,044  Aldose reductase substrate
0,138  0,001  Hypoxanthine phosphoribosyltransferase inhibitor
0,179  0,043  Antiprotozoal (Coccidial)
0,186  0,051  Cystic fibrosis treatment
0,255  0,122  Apoptosis antagonist
0,154  0,028  Antineoplastic, alkylator
0,130  0,003  Postcoital contraceptive
0,136  0,013  Interferon agonist
0,122  0,001  Purinergic P2Y15 antagonist
0,216  0,096  Antihypercholesterolemic
0,128  0,009  Phosphorylase inhibitor
0,145  0,027  Transcription factor STAT6 inhibitor
0,155  0,038  Growth stimulant
0,237  0,119  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,234  0,116  NOS3 expression inhibitor
0,199  0,086  Antineoplastic (glioblastoma multiforme)
0,136  0,022  Thioredoxin inhibitor
0,117  0,004  Inosine monophosphate dehydrogenase inhibitor
0,132  0,021  Transcription factor NF kappa B stimulant
0,206  0,102  Antineoplastic (non-small cell lung cancer)
0,116  0,017  Protein kinase C alpha inhibitor
0,108  0,010  Protein kinase C beta inhibitor
0,128  0,031  Protein kinase A inhibitor
0,132  0,035  Chronic obstructive bronchitis treatment
0,100  0,003  Purinergic P2X agonist
0,136  0,040  EphA2 antagonist
0,103  0,010  MAP kinase kinase 7 inhibitor
0,144  0,052  Antihemorrhagic
0,191  0,099  ErbB-1 antagonist
0,103  0,011  Interferon inducer
0,157  0,066  Pulmonary hypertension treatment
0,218  0,130  CYP1A2 substrate
0,141  0,054  Epidermal growth factor receptor kinase inhibitor
0,158  0,071  Carcinogenic, group 1
0,184  0,101  Transplant rejection treatment
0,170  0,088  Platelet adhesion inhibitor
0,201  0,120  MAP kinase kinase 3 inhibitor
0,083  0,002  Guanylate cyclase inhibitor
0,287  0,208  Caspase 9 stimulant
0,177  0,098  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,079  0,002  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,083  0,006  Purinergic P2T antagonist
0,160  0,083  Aldehyde oxidase substrate
0,095  0,018  Phosphodiesterase VIII inhibitor
0,125  0,048  Protein kinase C gamma inhibitor
0,143  0,070  Ribosomal protein S6 kinase inhibitor
0,121  0,048  AMP-activated protein kinase stimulant
0,218  0,145  Caspase 3 stimulant
0,166  0,094  Hepatoprotectant
0,189  0,118  Myocardial infarction treatment
0,205  0,137  Antiischemic
0,117  0,051  Vasculitis treatment
0,084  0,018  Protein 50S ribosomal subunit inhibitor
0,103  0,039  ErbB-3 antagonist
0,099  0,036  Proto-oncogene tyrosine-protein kinase c-hck inhibitor
0,106  0,042  Carcinogenic, group 2A
0,064  0,002  Isoleucine-tRNA ligase inhibitor
0,073  0,010  Thymidylate synthase inhibitor
0,103  0,041  Phosphodiesterase I inhibitor
0,083  0,022  Protein kinase C eta inhibitor
0,061  0,004  Inosine monophosphate dehydrogenase 1 inhibitor
0,060  0,004  Inosine monophosphate dehydrogenase 2 inhibitor
0,063  0,008  Antibiotic Aminoglycoside-like
0,140  0,085  MAP kinase 3 inhibitor
0,059  0,005  Purinergic P2Y12 antagonist
0,139  0,086  MAP kinase kinase 4 inhibitor
0,053  0,001  Methylmalonyl-CoA mutase inhibitor
0,192  0,140  UGT1A9 substrate
0,090  0,038  T cell inhibitor
0,170  0,119  Antineoplastic (glioma)
0,111  0,061  Topoisomerase I inhibitor
0,053  0,004  Purinergic P2Y1 antagonist
0,091  0,045  mTOR complex 2 inhibitor
0,102  0,056  UGT2B11 substrate
0,197  0,151  Antipsoriatic
0,060  0,015  Purinergic P2X4 antagonist
0,170  0,126  Platelet antagonist
0,047  0,003  Purinergic receptor agonist
0,047  0,003  Purinergic P2 agonist
0,051  0,008  Uridine phosphorylase inhibitor
0,057  0,016  Cytokine production stimulant
0,097  0,058  Phosphodiesterase 6D inhibitor
0,197  0,158  Metabolic disease treatment
0,040  0,002  Purine nucleoside phosphorylase inhibitor
0,047  0,011  HCV NS5B polymerase inhibitor
0,040  0,003  Purinergic P2Y agonist
0,164  0,129  Antiprotozoal (Leishmania)
0,089  0,054  Epidermal growth factor antagonist
0,033  0,001  Purinergic P2Y2 agonist
0,099  0,067  Folate antagonist
0,069  0,039  Purinergic P2 antagonist
0,109  0,079  Interleukin 8 antagonist
0,031  0,003  O6-alkylguanine-DNA alkyltransferase inhibitor
0,074  0,046  HIV-1 reverse transcriptase inhibitor
0,077  0,050  Antibiotic
0,118  0,092  Interleukin 1 antagonist
0,090  0,065  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,100  0,077  Mucolytic
0,125  0,103  Insulin secretagoues
0,040  0,018  RNA-directed RNA polymerase inhibitor
0,227  0,207  DNA directed DNA polymerase inhibitor
0,133  0,115  Myocardial ischemia treatment
0,046  0,030  Mannosidase inhibitor
0,110  0,093  Protein-tyrosine kinase Lyn inhibitor
0,053  0,037  Alpha-mannosidase inhibitor
0,116  0,101  UGT2B15 substrate
0,061  0,045  Antimycoplasmal
0,038  0,024  Arginase inhibitor
0,204  0,190  Stroke treatment
0,169  0,156  Nitric-oxide synthase stimulant
0,074  0,062  Antineoplastic antibiotic
0,184  0,173  Hepatic disorders treatment
0,138  0,128  Antiarrhythmic
0,082  0,074  Protein kinase C delta inhibitor
0,048  0,041  Antiviral (Hepatitis D)
0,045  0,038  Glucose-6-phosphate isomerase inhibitor
0,024  0,017  Protein 30S ribosomal subunit inhibitor
0,051  0,045  Phosphatidylinositol 3-kinase delta inhibitor
0,080  0,074  Hematopoietic
0,085  0,079  Ephrin antagonist
0,031  0,027  Purinergic P2Y2 antagonist
0,095  0,092  Antitussive
0,259  0,257  Antiinflammatory
0,004  0,002  Purinergic P2Y6 agonist
0,206  0,205  Calcium channel activator

